Botulinum toxin A during pregnancy: A survey of treating physicians

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 77, Issue 1, 2006, Pages 117-119

  Morgan, J C ^a   Iyer, S S ^a   Moser, E T ^a   Singer, C ^b   Sethi, K D ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

ABORTION; CONTROLLED STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; HEALTH SURVEY; HUMAN; PHYSICIAN; PREGNANCY; PRIORITY JOURNAL; QUESTIONNAIRE; REVIEW; TREATMENT OUTCOME;

BEAUTY; BOTULINUM TOXIN TYPE A; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INJECTIONS, SUBCUTANEOUS; NEUROMUSCULAR AGENTS; PHYSICIANS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; QUESTIONNAIRES; SURGERY, PLASTIC;

EID: 29644431658     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.2005.063792     Document Type: Review

References (19)

1. Newman WJ, Davis TL, Padaliya BB, et al. Botulinum toxin type A therapy during pregnancy. Mov Disord 2004;19:1384-5.
2. Allergan Pharmaceuticals. BOTOX package insert, July 2004.
3. Moser E, Ligon KM, Singer C, et al. Botulinum toxin A therapy during pregnancy. Neurology 1997;48(suppl):399.
4. Simpson LL. Molecular pharmacology of botulinum toxin and tetanus toxin. Ann Rev Pharmacol Toxicol 1986;26:427-53.
5. Hildebrand GJ, Lamana C, Heckly RJ. Distribution and particle and particle size of type A botulinum toxin in body fluids of intravenously injected rabbits. Proc Soc Exp Biol Med 1961;107:284-9.
6. Polo JM, Martin J, Berciano J. Botulism and pregnancy. Lancet 1996;348:195.
7. Type A botulism-Idaho, Oregon, 1973. MMWR Morb Mortal Wkly Rep 1973;22:218.
8. St Clair EH, DiLiberti JH, O'Brien ML. Observations of an infant born to a mother with botulism. J Pediatr 1975;87:658.
9. Wound botulism-California, 1995. MMWR Morb Mortal Wkly Rep 1995;44:889-92.
10. Robin L, Herman D, Redett R. Botulism in a pregnant women. N Engl J Med 1996;335:823-4.
11. Garza JJ, Downard CD, Clayton N, et al. Clostridium botulinum toxin inhibits myometrial activity in vitro: possible application on the prevention of preterm labor after fetal surgery. J Pediatr Surg 2003;38:511-13.
12. Sanders DB, Massey EW, Buckley EG. Botulinum toxin for blepharospasm: single-fiber EMG studies. Neurology 1986;36:545-7.
13. Lange DJ, Brin MF, Warner CL, et al. Distant effects of local injection of botulinum toxin. Muscle Nerve 1987;10:552-5.
14. Lange DJ, Rubin M, Greene PE, et al. Distant effects of locally injected botulinum toxin: a double-blind study of single fiber EMG changes. Muscle Nerve 1991;14:672-5.
15. 125I-botulinum- free neurotoxin: time course of tissue distribution. Toxicon 2003;42:461-9.
16. Fertl E, Schnider P, Schneider B, et al. Remote effects of chronic botulinum toxin treatment: electrophysiologic results do not indicate subclinical remodeling of noninjected muscles. Eur Neurol 2000;44:139-43.
17. McAvoy BR, Kaner EF. General practice postal surveys: a questionnaire too far? BMJ 1996;313:732-3.
18. Cerssimo MG, Bertoti A, Roca CU, et al. Botulinum toxin in a case of hemimasticatory spasm with severe worsening during pregnancy. Clin Neuropharmacol 2004;27:6-8.
19. Fuinucane AK. Legal issues in neurology and pregnancy. The physician's duty of care. Neurol Clin 1994;12:637-53.